TOTAL VOLUME:
$134.1b
24H VOL:
$113,466,932
24H TRANSACTIONS:
2,388,728,490
OPEN INTEREST:
$1,423,222,590
402,751
Markets across
30,217
events
MATCHED EVENTS:
2,632
PLATFORM COVERAGE:
5
Polymarket:
39%
VS.
Kalshi:
61%
Closed: Jun 2, 12:11 PM EST
Kalshi
This market on Kalshi tracks whether President Trump will issue an executive action establishing or directing a federal review process for AI models before their public release. The leading outcome—that such an action occurs before January 1, 2027—stands at 64.0%, while the probability of an executive action by July 1, 2026 is 10.0%. Resolution is based on whether Trump takes any executive action establishing or directing a federal AI review process for pre-release models before the January 1, 2027 deadline. Watch for announcements of executive orders or formal directives from the White House regarding AI model oversight in the coming months leading up to the resolution date.
The market resolves on Jan 1, 2027. Resolution hinges on whether Trump issues an executive action that explicitly establishes or directs a federal review process for AI models before their public release. The outcome is binary: either such an action is issued by the deadline, or it is not. Traders should monitor executive orders, White House announcements, and regulatory agency directives for evidence of a formal pre-release review mandate. The specific language and scope of any order will be evaluated against the market's resolution criteria at settlement.
Key catalysts include major AI incidents or breaches that prompt regulatory calls, Congressional legislation on AI governance, statements from Trump or his advisors on AI policy priorities, and actions by federal agencies like the NIST or OMB. International AI regulation developments could influence U.S. policy momentum. Executive orders on related topics—such as AI safety standards or tech sector oversight—may signal Trump's willingness to intervene. Media coverage of AI risks and public pressure for guardrails could shift political calculus. Conversely, industry lobbying against pre-release review requirements and Trump's historical deregulatory preference may suppress the probability.